Epidemiology of Pneumocystis jirovecii Pneumonia and (Non-)use of Prophylaxis

Objectives: Pneumocystis jirovecii pneumonia (PCP) is an AIDS-defining illness. In patients with HIV, the benefit of PCP prophylaxis is well-defined when the CD4 T-cell count decreases below 200 cells/μL. In other immunocompromised patients, the value of PCP prophylaxis is not always as well-establi...

Descripción completa

Detalles Bibliográficos
Autores principales: Dunbar, Albert, Schauwvlieghe, Alexander, Algoe, Sheruna, van Hellemond, Jaap J., Reynders, Marijke, Vandecasteele, Stefaan, Boelens, Jerina, Depuydt, Pieter, Rijnders, Bart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243458/
https://www.ncbi.nlm.nih.gov/pubmed/32500040
http://dx.doi.org/10.3389/fcimb.2020.00224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243458/
https://www.ncbi.nlm.nih.gov/pubmed/32500040
http://dx.doi.org/10.3389/fcimb.2020.00224

Ejemplares similares